L. Leong
- Oncology top 5%
- Cancer Treatment and Pharmacology 10
- Colorectal Cancer Treatments and Studies 8
- Cancer Cells and Metastasis 3
- HER2/EGFR in Cancer Research 3
- Hepatology top 5%
- Hematology top 10%
- Pathology and Forensic Medicine top 10%
-
- Lung Cancer Treatments and Mutations 5
- Brain Metastases and Treatment 3
-
- Ovarian cancer diagnosis and treatment 5
-
- Cancer therapeutics and mechanisms 4
- Co-authors
- Kim MargolinJames H. DoroshowSteven A. AkmanM BertrandGeorge SomloBrian I. CarrJames RaschkoLawrence D. Wagman
- Cited by
- OncologyHepatologyCancer Research
- Journals
- Journal of Clinical Oncology (17 papers)British Journal of Cancer (2 papers)Cancer Chemotherapy and Pharmacology (2 papers)
- Partner nations
- United StatesItalySingapore
In The Last Decade
L. Leong
39 papers receiving 969 citations
Peers
Comparison fields: 5 of 79
- Oncology 648
- Hepatology 188
- Cancer Research 143
- Hematology 100
- Pathology and Forensic Medicine 144
Countries citing papers authored by L. Leong
This map shows the geographic impact of L. Leong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Leong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Leong more than expected).
Fields of papers citing papers by L. Leong
This network shows the impact of papers produced by L. Leong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Leong. The network helps show where L. Leong may publish in the future.
Co-authorship network
The 25 scholars most cited alongside L. Leong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 6 | |
| 2 | 2012 | 6 | |
| 3 | 2011 | 22 | |
| 4 | 2011 | 10 | |
| 5 | 2010 | 11 | |
| 6 | 2007 | 6 | |
| 7 | Embolotherapy with a Mixture of Lipiodol and Ethanol for Renal Angiomyolipoma: Retrospective Study | 2005 | 1 |
| 8 | 2002 | 22 | |
| 9 | 2001 | 6 | |
| 10 | 1997 | 63 | |
| 11 | 1997 | 1 | |
| 12 | 1996 | 59 | |
| 13 | 1995 | 13 | |
| 14 | 1992 | 18 | |
| 15 | 1992 | 7 | |
| 16 | 1992 | 19 | |
| 17 | 1990 | 178 | |
| 18 | 1990 | 190 | |
| 19 | 1989 | 48 | |
| 20 | Henoch-Schönlein purpura: simultaneous demonstration of IgA deposits in involved skin, intestine, and kidney. | 1982 | 33 |
About L. Leong
L. Leong is a scholar working on Oncology, Reproductive Medicine, Pulmonary and Respiratory Medicine, Cancer Research and Hematology, having authored 41 papers that have together received 1.0k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (10 papers), Colorectal Cancer Treatments and Studies (8 papers), Lung Cancer Treatments and Mutations (5 papers), Ovarian cancer diagnosis and treatment (5 papers), Cancer therapeutics and mechanisms (4 papers), Brain Metastases and Treatment (3 papers), Cancer Cells and Metastasis (3 papers) and HER2/EGFR in Cancer Research (3 papers). The work is most often cited by research in Oncology (648 citations), Hepatology (188 citations), Cancer Research (143 citations), Hematology (100 citations) and Pathology and Forensic Medicine (144 citations). L. Leong has collaborated with scholars based in United States, Italy and Singapore. Frequent co-authors include Kim Margolin, James H. Doroshow, Steven A. Akman, M Bertrand, George Somlo, Brian I. Carr, James Raschko, Lawrence D. Wagman, Daniel U. Riihimaki and William A. Kokal. Their work appears in journals such as Journal of Clinical Oncology, British Journal of Cancer, Cancer Chemotherapy and Pharmacology, Blood and International Journal of Gynecological Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.